Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation
1 clinical trials · Condition
◉ Watch Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation
| Record | Firm | Date |
|---|---|---|
| Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer (NCT02893917) | National Cancer Institute (NCI) | 2017-08-11 |
Track Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation automatically
Every clearance here is in the API, with alerts when new ones post.